FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2582120327> ?p ?o ?g. }

• W2582120327 endingPage "31" @default.
• W2582120327 startingPage "27" @default.
• W2582120327 abstract "ObjectivesVancomycin is the treatment of choice for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia; however, its use has been subject to scrutiny due to failure in severe infections. Ceftaroline fosamil (CPT-F) is approved for MRSA acute bacterial skin and skin structure infections, but not for bloodstream infections. The clinical outcomes of treatment with CPT-F in patients with MRSA bacteremia were evaluated.MethodsPatients diagnosed with MRSA bacteremia at Henry Ford Hospital in Detroit, Michigan, USA, involving isolates with a vancomycin minimum inhibitory concentration ≥1.0 mg/l and susceptible in vitro to CPT-F, were systematically reviewed retrospectively. Ceftaroline fosamil-treated patients were matched with at least two vancomycin- and/or one daptomycin-treated control patient based on age-patients age 65 years or greater or less than 65 years of age. Outcomes evaluated included the duration of hospitalization, duration of therapy, adverse events, relapse, hospital readmission, and death.ResultsThirty consecutive cases of MRSA bacteremia treated with CPT-F during the period May 2011 to June 2013 were identified; these patients were matched to 56 MRSA bacteremia patients treated with vancomycin and 46 MRSA bacteremia patients treated with daptomycin. The primary source of MRSA bacteremia in the cohort treated with CPT-F was endocarditis (n = 7, 23%), skin/wound (n = 9, 30%), and bone/joint (n = 8, 27%). The MRSA bacteremia in those treated with CPT-F was community-acquired in 43% of cases, healthcare-associated in 43%, and hospital-acquired in 13%. The mean length of hospital stay for these patients was 22 days. The overall 30-day mortality rate was 13% (n = 4) in CPT-F patients versus 24% (n = 11) in daptomycin patients and 11% (n = 6) in vancomycin patients (p = 0.188).ConclusionsCPT-F demonstrated comparable clinical outcomes in MRSA bacteremia patients compared with the other agents, especially as salvage therapy." @default.
• W2582120327 created "2017-02-03" @default.
• W2582120327 creator A5007517600 @default.
• W2582120327 creator A5014675014 @default.
• W2582120327 creator A5026992480 @default.
• W2582120327 creator A5035812199 @default.
• W2582120327 creator A5045626390 @default.
• W2582120327 creator A5069809340 @default.
• W2582120327 date "2017-04-01" @default.
• W2582120327 modified "2023-10-15" @default.
• W2582120327 title "Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study" @default.
• W2582120327 cites W1965508676 @default.
• W2582120327 cites W1973001029 @default.
• W2582120327 cites W2006458380 @default.
• W2582120327 cites W2011312924 @default.
• W2582120327 cites W2022278469 @default.
• W2582120327 cites W2056229483 @default.
• W2582120327 cites W2076664566 @default.
• W2582120327 cites W2099365065 @default.
• W2582120327 cites W2102463930 @default.
• W2582120327 cites W2114585210 @default.
• W2582120327 cites W2114641717 @default.
• W2582120327 cites W2121721918 @default.
• W2582120327 cites W2134162460 @default.
• W2582120327 cites W2135788092 @default.
• W2582120327 cites W2136296616 @default.
• W2582120327 cites W2143371514 @default.
• W2582120327 cites W2145830075 @default.
• W2582120327 cites W2160238480 @default.
• W2582120327 cites W2161279982 @default.
• W2582120327 cites W2161782404 @default.
• W2582120327 cites W2164724289 @default.
• W2582120327 cites W2166444268 @default.
• W2582120327 cites W2167218440 @default.
• W2582120327 cites W2168482920 @default.
• W2582120327 cites W2318169546 @default.
• W2582120327 cites W4214754383 @default.
• W2582120327 doi "https://doi.org/10.1016/j.ijid.2017.01.019" @default.
• W2582120327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28131729" @default.
• W2582120327 hasPublicationYear "2017" @default.
• W2582120327 type Work @default.
• W2582120327 sameAs 2582120327 @default.
• W2582120327 citedByCount "37" @default.
• W2582120327 countsByYear W25821203272017 @default.
• W2582120327 countsByYear W25821203272018 @default.
• W2582120327 countsByYear W25821203272019 @default.
• W2582120327 countsByYear W25821203272020 @default.
• W2582120327 countsByYear W25821203272021 @default.
• W2582120327 countsByYear W25821203272022 @default.
• W2582120327 countsByYear W25821203272023 @default.
• W2582120327 crossrefType "journal-article" @default.
• W2582120327 hasAuthorship W2582120327A5007517600 @default.
• W2582120327 hasAuthorship W2582120327A5014675014 @default.
• W2582120327 hasAuthorship W2582120327A5026992480 @default.
• W2582120327 hasAuthorship W2582120327A5035812199 @default.
• W2582120327 hasAuthorship W2582120327A5045626390 @default.
• W2582120327 hasAuthorship W2582120327A5069809340 @default.
• W2582120327 hasBestOaLocation W25821203271 @default.
• W2582120327 hasConcept C126322002 @default.
• W2582120327 hasConcept C141071460 @default.
• W2582120327 hasConcept C2775872228 @default.
• W2582120327 hasConcept C2777052132 @default.
• W2582120327 hasConcept C2777334864 @default.
• W2582120327 hasConcept C2778651397 @default.
• W2582120327 hasConcept C2778980435 @default.
• W2582120327 hasConcept C2779443120 @default.
• W2582120327 hasConcept C2779489039 @default.
• W2582120327 hasConcept C501593827 @default.
• W2582120327 hasConcept C523546767 @default.
• W2582120327 hasConcept C54355233 @default.
• W2582120327 hasConcept C71924100 @default.
• W2582120327 hasConcept C86803240 @default.
• W2582120327 hasConcept C89423630 @default.
• W2582120327 hasConceptScore W2582120327C126322002 @default.
• W2582120327 hasConceptScore W2582120327C141071460 @default.
• W2582120327 hasConceptScore W2582120327C2775872228 @default.
• W2582120327 hasConceptScore W2582120327C2777052132 @default.
• W2582120327 hasConceptScore W2582120327C2777334864 @default.
• W2582120327 hasConceptScore W2582120327C2778651397 @default.
• W2582120327 hasConceptScore W2582120327C2778980435 @default.
• W2582120327 hasConceptScore W2582120327C2779443120 @default.
• W2582120327 hasConceptScore W2582120327C2779489039 @default.
• W2582120327 hasConceptScore W2582120327C501593827 @default.
• W2582120327 hasConceptScore W2582120327C523546767 @default.
• W2582120327 hasConceptScore W2582120327C54355233 @default.
• W2582120327 hasConceptScore W2582120327C71924100 @default.
• W2582120327 hasConceptScore W2582120327C86803240 @default.
• W2582120327 hasConceptScore W2582120327C89423630 @default.
• W2582120327 hasLocation W25821203271 @default.
• W2582120327 hasLocation W25821203272 @default.
• W2582120327 hasLocation W25821203273 @default.
• W2582120327 hasOpenAccess W2582120327 @default.
• W2582120327 hasPrimaryLocation W25821203271 @default.
• W2582120327 hasRelatedWork W2044565499 @default.
• W2582120327 hasRelatedWork W2078444411 @default.
• W2582120327 hasRelatedWork W2106310886 @default.
• W2582120327 hasRelatedWork W2140683589 @default.
• W2582120327 hasRelatedWork W2144963218 @default.

• next